Plasmodial sugar transporters as anti-malarial drug targets and comparisons with other protozoa

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Slavic, Ksenija ^a,b   Krishna, Sanjeev ^a   Derbyshire, Elvira T ^a   Staines, Henry M ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; GLUCOSE; HEXOSE; GLUCOSE TRANSPORTER;

BABESIA BOVIS; COMPARATIVE STUDY; DRUG TARGETING; ENERGY YIELD; GENE EXPRESSION; GLUCOSE TRANSPORT; GLYCOLYSIS; HEXOSE TRANSPORT; LEISHMANIA; MALARIA; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM; PLASMODIUM FALCIPARUM; REVIEW; SPECIES DIFFERENCE; TOXOPLASMA; TRYPANOSOMA; VALIDATION STUDY; XENOPUS LAEVIS; ANIMAL; CARBOHYDRATE METABOLISM; DRUG ANTAGONISM; DRUG DEVELOPMENT; DRUG EFFECT; HUMAN; METABOLISM; APICOMPLEXA; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; GENETIC ANALYSIS; HIGH THROUGHPUT SCREENING; LIFE CYCLE; PROTOZOON; SUGAR TRANSPORT; TOXOPLASMA GONDII;

ANIMALS; ANTIMALARIALS; CARBOHYDRATE METABOLISM; DRUG DISCOVERY; HUMANS; MONOSACCHARIDE TRANSPORT PROTEINS; PLASMODIUM FALCIPARUM;

EID: 79958773298     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-165     Document Type: Review

References (68)

1. Malaria rapid tests: a public health perspective. C Wongsrichanalai RS Miller, Lancet 2002 359 1781 12049900 (Pubitemid 34607103)
2. Artemisinins: activities and actions. RK Haynes S Krishna, Microbes Infect 2004 6 1339 1346 10.1016/j.micinf.2004.09.002 15555542 (Pubitemid 39539733)
3. Antimalarial combinations. PG Kremsner S Krishna, Lancet 2004 364 285 294 10.1016/S0140-6736(04)16680-4 15262108
4. Artemisinins: their growing importance in medicine. S Krishna L Bustamante RK Haynes HM Staines, Trends Pharmacol Sci 2008 29 520 527 10.1016/j.tips.2008.07.004 18752857
5. Qinghaosu (artemisinin): the price of success. NJ White, Science 2008 320 330 334 10.1126/science.1155165 18420924 (Pubitemid 351555649)
6. WHO, World Malaria Report Geneva: WHO Press 2008 1 215
7. Artemisinin resistance in Plasmodium falciparum malaria. AM Dondorp F Nosten P Yi D Das AP Phyo J Tarning KM Lwin F Ariey W Hanpithakpong SJ Lee P Ringwald K Silamut M Imwong K Chotivanich P Lim T Herdman SS An S Yeung P Singhasivanon NP Day N Lindegardh D Socheat NJ White, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
8. Evidence of artemisinin-resistant malaria in western Cambodia. H Noedl Y Se K Schaecher BL Smith D Socheat MM Fukuda, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
9. Artemisinin-resistant malaria in Asia. H Noedl D Socheat W Satimai, N Engl J Med 2009 361 540 541 10.1056/NEJMc0900231 19641219
10. Exploiting the therapeutic potential of Plasmodium falciparum solute transporters. HM Staines ET Derbyshire K Slavic A Tattersall H Vial S Krishna, Trends Parasitol 2010 26 284 296 10.1016/j.pt.2010.03.004 20392668
11. pH regulation in the intracellular malaria parasite, Plasmodium falciparum. H(+) extrusion via a v-type h(+)-atpase. KJ Saliba K Kirk, J Biol Chem 1999 274 33213 33219 10.1074/jbc.274.47.33213 10559194 (Pubitemid 129511618)
12. The membrane potential of the intraerythrocytic malaria parasite Plasmodium falciparum. RJ Allen K Kirk, J Biol Chem 2004 279 11264 11272 10.1074/jbc.M311110200 14630911 (Pubitemid 38401623)
13. Branched tricarboxylic acid metabolism in Plasmodium falciparum. KL Olszewski MW Mather JM Morrisey BA Garcia AB Vaidya JD Rabinowitz M Llinas, Nature 2010 466 774 778 10.1038/nature09301 20686576
14. Facilitated hexose transporters: new perspectives on form and function. AR Manolescu K Witkowska A Kinnaird T Cessford C Cheeseman, Physiology (Bethesda) 2007 22 234 240
15. A nutrient-permeable channel on the intraerythrocytic malaria parasite. SA Desai DJ Krogstad EW McCleskey, Nature 1993 362 643 646 10.1038/362643a0 7681937 (Pubitemid 23109275)
16. Pore size of the malaria parasite's nutrient channel. SA Desai RL Rosenberg, Proc Natl Acad Sci USA 1997 94 2045 2049 10.1073/pnas.94.5.2045 9050902 (Pubitemid 27113959)
17. Glucose uptake in Plasmodium falciparum-infected erythrocytes is an equilibrative not an active process. K Kirk HA Horner J Kirk, Mol Biochem Parasitol 1996 82 195 205 10.1016/0166-6851(96)02734-X 8946385 (Pubitemid 26375825)
18. Intraerythrocytic Plasmodium falciparum expresses a high affinity facilitative hexose transporter. CJ Woodrow JI Penny S Krishna, J Biol Chem 1999 274 7272 7277 10.1074/jbc.274.11.7272 10066789
19. Hexose permeation pathways in Plasmodium falciparum-infected erythrocytes. CJ Woodrow RJ Burchmore S Krishna, Proc Natl Acad Sci USA 2000 97 9931 9936 10954735
20. Human erythrocytes express GLUT5 and transport fructose. FV Velasquez JM Martinez C Angulo A Droppelmann AM Reyes JC Slebe JC Vera DW Golde, Blood 1997 89 4190 4195 9166863 (Pubitemid 27220969)
21. Genome sequence of the human malaria parasite Plasmodium falciparum. MJ Gardner N Hall E Fung O White M Berriman RW Hyman JM Carlton A Pain KE Nelson S Bowman IT Paulsen K James JA Eisen K Rutherford SL Salzberg A Craig S Kyes MS Chan V Nene SJ Shallom B Suh J Peterson S Angiuoli M Pertea J Allen J Selengut D Haft MW Mather AB Vaidya DM Martin AH Fairlamb MJ Fraunholz DS Roos SA Ralph GI McFadden LM Cummings GM Subramanian C Mungall JC Venter DJ Carucci SL Hoffman C Newbold RW Davis CM Fraser B Barrell, Nature 2002 419 498 511 10.1038/nature01097 12368864
22. The 'permeome' of the malaria parasite: an overview of the membrane transport proteins of Plasmodium falciparum. RE Martin RI Henry JL Abbey JD Clements K Kirk, Genome Biol 2005 6 26 10.1186/gb-2005-6-3-r26 15774027
23. Transport processes in Plasmodium falciparum-infected erythrocytes: potential as new drug targets. S Krishna U Eckstein-Ludwig T Joet AC Uhlemann C Morin R Webb C Woodrow JF Kun PG Kremsner, Int J Parasitol 2002 32 1567 1573 10.1016/S0020-7519(02)00185-6 12435441 (Pubitemid 35335999)
24. The evolution, metabolism and functions of the apicoplast. L Lim GI McFadden, Philos Trans R Soc Lond B Biol Sci 2010 365 749 763 10.1098/rstb.2009.0273 20124342
25. Membrane transporters in the relict plastid of malaria parasites. KA Mullin L Lim SA Ralph TP Spurck E Handman GI McFadden, Proc Natl Acad Sci USA 2006 103 9572 9577 10.1073/pnas.0602293103 16760253 (Pubitemid 43955866)
26. The carbon and energy sources of the non-photosynthetic plastid in the malaria parasite. L Lim M Linka KA Mullin AP Weber GI McFadden, FEBS Lett 2010 584 549 554 10.1016/j.febslet.2009.11.097 19968990
27. Functional genomics: identifying drug targets for parasitic diseases. AF Cowman BS Crabb, Trends Parasitol 2003 19 538 543 10.1016/j.pt.2003.09.006 14580967 (Pubitemid 37329665)
28. Target assessment for antiparasitic drug discovery. JA Frearson PG Wyatt IH Gilbert AH Fairlamb, Trends Parasitol 2007 23 589 595 10.1016/j.pt.2007.08. 019 17962072 (Pubitemid 350161429)
29. Amplification of an alternate transporter gene suppresses the avirulent phenotype of glucose transporter null mutants in Leishmania mexicana. X Feng D Rodriguez-Contreras C Buffalo HG Bouwer E Kruvand SM Beverley SM Landfear, Mol Microbiol 2009 71 369 381 10.1111/j.1365-2958.2008.06531.x 19017272
30. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target. T Joet U Eckstein-Ludwig C Morin S Krishna, Proc Natl Acad Sci USA 2003 100 7476 7479 10.1073/pnas.1330865100 12792024 (Pubitemid 36759994)
31. Inhibition of hexose transport and abrogation of pH homeostasis in the intraerythrocytic malaria parasite by an O-3-hexose derivative. KJ Saliba S Krishna K Kirk, FEBS Lett 2004 570 93 96 10.1016/j.febslet.2004.06.032 15251446 (Pubitemid 38900963)
32. Analysis of Plasmodium vivax hexose transporters and effects of a parasitocidal inhibitor. T Joet K Chotivanich K Silamut AP Patel C Morin S Krishna, Biochem J 2004 381 905 909 10.1042/BJ20040433 15107012 (Pubitemid 39120502)
33. Probing structure/affinity relationships for the Plasmodium falciparum hexose transporter with glucose derivatives. M Fayolle M Ionita S Krishna C Morin AP Patel, Bioorg Med Chem Lett 2006 16 1267 1271 10.1016/j.bmcl.2005.11. 068 16361099 (Pubitemid 43143003)
34. Interaction of O-(undec-10-en)-yl-D-glucose derivatives with the Plasmodium falciparum hexose transporter (PfHT). M Ionita S Krishna PM Leo C Morin AP Patel, Bioorg Med Chem Lett 2007 17 4934 4937 10.1016/j.bmcl.2007.06. 021 17587575 (Pubitemid 47187679)
35. Comparison of effects of green tea catechins on apicomplexan hexose transporters and mammalian orthologues. K Slavic ET Derbyshire RJ Naftalin S Krishna HM Staines, Mol Biochem Parasitol 2009 168 113 116 10.1016/j.molbiopara. 2009.06.008 19577593
36. Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1. RJ Naftalin I Afzal P Cunningham M Halai C Ross N Salleh SR Milligan, Br J Pharmacol 2003 140 487 499 10.1038/sj.bjp.0705460 12970085 (Pubitemid 37330493)
37. Antimalarial properties of green tea. AR Sannella L Messori A Casini F Francesco Vincieri AR Bilia G Majori C Severini, Biochem Biophys Res Commun 2007 353 177 181 10.1016/j.bbrc.2006.12.005 17174271 (Pubitemid 44970448)
38. Functional characterization of both MAP kinases of the human malaria parasite Plasmodium falciparum by reverse genetics. D Dorin-Semblat N Quashie J Halbert A Sicard C Doerig E Peat L Ranford-Cartwright C Doerig, Mol Microbiol 2007 65 1170 1180 10.1111/j.1365-2958.2007.05859.x 17651389 (Pubitemid 47262821)
39. Life cycle studies of the hexose transporter of Plasmodium species and genetic validation of their essentiality. K Slavic U Straschil L Reininger C Doerig C Morin R Tewari S Krishna, Mol Microbiol 2010 75 1402 1413 10.1111/j.1365-2958.2010.07060.x 20132450
40. A constitutive pan-hexose permease for the Plasmodium life cycle and transgenic models for screening of antimalarial sugar analogs. M Blume M Hliscs D Rodriguez-Contreras M Sanchez S Landfear R Lucius K Matuschewski N Gupta, FASEB J 2011 25 1218 1229 10.1096/fj.10-173278 21169382
41. Use of a selective inhibitor to define the chemotherapeutic potential of the plasmodial hexose transporter in different stages of the parasite's life cycle. K Slavic MJ Delves M Prudencio AM Talman U Straschil ET Derbyshire Z Xu RE Sinden MM Mota C Morin R Tewari S Krishna HM Staines, Antimicrob Agents Chemother 2011 55 2824 2830 10.1128/AAC.01739-10 21402842
42. A proteomic view of the Plasmodium falciparum life cycle. L Florens MP Washburn JD Raine RM Anthony M Grainger JD Haynes JK Moch N Muster JB Sacci DL Tabb AA Witney D Wolters Y Wu MJ Gardner AA Holder RE Sinden JR Yates DJ Carucci, Nature 2002 419 520 526 10.1038/nature01107 12368866
43. A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. N Hall M Karras JD Raine JM Carlton TW Kooij M Berriman L Florens CS Janssen A Pain GK Christophides K James K Rutherford B Harris D Harris C Churcher MA Quail D Ormond J Doggett HE Trueman J Mendoza SL Bidwell MA Rajandream DJ Carucci JR Yates FC Kafatos CJ Janse B Barrell CM Turner AP Waters RE Sinden, Science 2005 307 82 86 10.1126/science.1103717 15637271 (Pubitemid 40093481)
44. Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. E Lasonder Y Ishihama JS Andersen AM Vermunt A Pain RW Sauerwein WM Eling N Hall AP Waters HG Stunnenberg M Mann, Nature 2002 419 537 542 10.1038/nature01111 12368870
45. Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity. E Lasonder CJ Janse GJ van Gemert GR Mair AM Vermunt BG Douradinha V van Noort MA Huynen AJ Luty H Kroeze SM Khan RW Sauerwein AP Waters M Mann HG Stunnenberg, PLoS Pathog 2008 4 1000195 10.1371/journal.ppat.1000195 18974882
46. A combined transcriptome and proteome survey of malaria parasite liver stages. AS Tarun X Peng RF Dumpit Y Ogata H Silva-Rivera N Camargo TM Daly LW Bergman SH Kappe, Proc Natl Acad Sci USA 2008 105 305 310 10.1073/pnas. 0710780104 18172196
47. The role of anti-malarial drugs in eliminating malaria. NJ White, Malar J 2008 7 Suppl 1 8 10.1186/1475-2875-7-S1-S8 19091042
48. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. E Beutler S Duparc, Am J Trop Med Hyg 2007 77 779 789 17978087 (Pubitemid 351844308)
49. The silent path to thousands of merozoites: the Plasmodium liver stage. M Prudencio A Rodriguez MM Mota, Nat Rev Microbiol 2006 4 849 856 10.1038/nrmicro1529 17041632 (Pubitemid 44593951)
50. An expression system to screen for inhibitors of parasite glucose transporters. T Feistel CA Hodson DH Peyton SM Landfear, Mol Biochem Parasitol 2008 162 71 76 10.1016/j.molbiopara.2008.07.005 18708094
51. Phenotypic characterization of a glucose transporter null mutant in Leishmania mexicana. D Rodriguez-Contreras X Feng KM Keeney HG Bouwer SM Landfear, Mol Biochem Parasitol 2007 153 9 18 10.1016/j.molbiopara.2007.01.010 17306380 (Pubitemid 46517669)
52. Thousands of chemical starting points for antimalarial lead identification. FJ Gamo LM Sanz J Vidal C de Cozar E Alvarez JL Lavandera DE Vanderwall DV Green V Kumar S Hasan JR Brown CE Peishoff LR Cardon JF Garcia-Bustos, Nature 2010 465 305 310 10.1038/nature09107 20485427
53. Chemical genetics of Plasmodium falciparum. WA Guiguemde AA Shelat D Bouck S Duffy GJ Crowther PH Davis DC Smithson M Connelly J Clark F Zhu MB Jimenez-Diaz MS Martinez EB Wilson AK Tripathi J Gut ER Sharlow I Bathurst F El Mazouni JW Fowble I Forquer PL McGinley S Castro I Angulo-Barturen S Ferrer PJ Rosenthal JL Derisi DJ Sullivan JS Lazo DS Roos MK Riscoe MA Phillips PK Rathod WC Van Voorhis VM Avery RK Guy, Nature 2010 465 311 315 10.1038/nature09099 20485428
54. Glycolysis as a target for the design of new anti-trypanosome drugs. CL Verlinde V Hannaert C Blonski M Willson JJ Perie LA Fothergill-Gilmore FR Opperdoes MH Gelb WG Hol PA Michels, Drug Resist Updat 2001 4 50 65 10.1054/drup.2000.0177 11512153 (Pubitemid 32267825)
55. Interaction of substituted hexose analogues with the Trypanosoma brucei hexose transporter. L Azema S Claustre I Alric C Blonski M Willson J Perie T Baltz E Tetaud F Bringaud D Cottem FR Opperdoes MP Barrett, Biochem Pharmacol 2004 67 459 467 10.1016/j.bcp.2003.09.005 15037198 (Pubitemid 38232886)
56. Genetic characterization of glucose transporter function in Leishmania mexicana. RJ Burchmore D Rodriguez-Contreras K McBride P Merkel MP Barrett G Modi D Sacks SM Landfear, Proc Natl Acad Sci USA 2003 100 3901 3906 10.1073/pnas.0630165100 12651954 (Pubitemid 36418129)
57. Differential regulation of multiple glucose transporter genes in Leishmania mexicana. RJ Burchmore SM Landfear, J Biol Chem 1998 273 29118 29126 10.1074/jbc.273.44.29118 9786920 (Pubitemid 28507610)
58. Identification, expression and characterisation of a Babesia bovis hexose transporter. ET Derbyshire FJ Franssen E de Vries C Morin CJ Woodrow S Krishna HM Staines, Mol Biochem Parasitol 2008 161 124 129 10.1016/j.molbiopara.2008.06. 010 18638508
59. Host-derived glucose and its transporter in the obligate intracellular pathogen Toxoplasma gondii are dispensable by glutaminolysis. M Blume D Rodriguez-Contreras S Landfear T Fleige D Soldati-Favre R Lucius N Gupta, Proc Natl Acad Sci USA 2009 106 12998 13003 10.1073/pnas.0903831106 19617561
60. N-acetyl D-glucosamine stimulates growth in procyclic forms of Trypanosoma brucei by inducing a metabolic shift. CE Ebikeme L Peacock V Coustou L Riviere F Bringaud WC Gibson MP Barrett, Parasitology 2008 135 585 594 18371239 (Pubitemid 351572126)
61. A glucose transporter can mediate ribose uptake: definition of residues that confer substrate specificity in a sugar transporter. CM Naula FJ Logan PE Wong MP Barrett RJ Burchmore, J Biol Chem 2010 285 29721 29728 10.1074/jbc.M110.106815 20601430
62. Transport of diverse substrates into malaria-infected erythrocytes via a pathway showing functional characteristics of a chloride channel. K Kirk HA Horner BC Elford JC Ellory CI Newbold, J Biol Chem 1994 269 3339 3347 8106373 (Pubitemid 24237649)
63. Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan family. T Joet L Holterman TT Stedman CH Kocken A Van Der Wel AW Thomas S Krishna, Biochem J 2002 368 923 929 10.1042/BJ20021189 12238947 (Pubitemid 36042695)
64. Contribution of glucose transport to the control of the glycolytic flux in Trypanosoma brucei. BM Bakker MC Walsh BH ter Kuile FI Mensonides PA Michels FR Opperdoes HV Westerhoff, Proc Natl Acad Sci USA 1999 96 10098 10103 10.1073/pnas.96.18.10098 10468568 (Pubitemid 29422518)
65. Trypanosome glucose transporters. MP Barrett E Tetaud A Seyfang F Bringaud T Baltz, Mol Biochem Parasitol 1998 91 195 205 10.1016/S0166-6851(97) 00192-8 9574935
66. Kinetoplastid glucose transporters. E Tetaud MP Barrett F Bringaud T Baltz, Biochem J 1997 325 Pt 3 569 580 9271074 (Pubitemid 27367743)
67. Glucose uptake in Trypanosoma vivax and molecular characterization of its transporter gene. JN Waitumbi E Tetaud T Baltz, Eur J Biochem 1996 237 234 239 10.1111/j.1432-1033.1996.0234n.x 8620878 (Pubitemid 26110293)
68. Cloning and functional characterization of the mouse fructose transporter, GLUT5. CP Corpe FJ Bovelander CM Munoz JH Hoekstra IA Simpson O Kwon M Levine CF Burant, Biochim Biophys Acta 2002 1576 191 197 12031501 (Pubitemid 34597101)